APPLICATION
NDA021496
TYPE
NDA
ORIGINAL APPROVAL
2003-05-23
LATEST ACTION
2003-05-23
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
DUOCAINEDiscontinued
BUPIVACAINE HYDROCHLORIDE EQ 0.375% (37.5MG/10ML), LIDOCAINE HYDROCHLORIDE EQ 1% (100MG/10ML) · INJECTABLE · INJECTION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.